SPECIAL PRODUCTS LIMITED

Dissolved London

Agents specialized in the sale of other particular products

0 employees website.com
Agents specialized in the sale of other particular products
S

SPECIAL PRODUCTS LIMITED

Agents specialized in the sale of other particular products

Founded 22 Jul 2011 Dissolved London, England 0 employees website.com
Agents specialized in the sale of other particular products

Previous Company Names

VERITON PHARMA LIMITED 2 Mar 2017 — 29 Sept 2017
WOODSTOCK HEALTH LIMITED 22 Jul 2011 — 2 Mar 2017
Accounts Submitted 22 Feb 2024 Next due 30 Sept 2025 8 months overdue
Confirmation Submitted 2 Jul 2025 Next due 5 Jul 2026 2 months remaining
Net assets £-1K £0 2023 year on year
Total assets £0
Total Liabilities £1K £0 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

St. Martin's Court 10 Paternoster Row London EC4M 7EJ England

Full company profile for SPECIAL PRODUCTS LIMITED (07714916), a dissolved company based in London, England. Incorporated 22 Jul 2011. Agents specialized in the sale of other particular products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

N/A

Net Assets

-£1.00k

Total Liabilities

£1.00k

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Patel, Janit VishnuprasadDirectorBritishEngland5622 Feb 2021Active

Shareholders

Shareholders (1)

Veriton Pharma Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Veriton Pharma Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

VERITON PHARMA LIMITED united kingdom
SPECIAL PRODUCTS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Mar 2026GazetteGazette Dissolved Voluntary
2 Jul 2025Confirmation StatementConfirmation statement made on 21 Jun 2025 with no updates
24 Jun 2025OfficersTermination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025
9 Jan 2025OfficersAppointment of Samuel Jenkinson as director on 1 Jan 2025
9 Jan 2025OfficersTermination of Anthony Higham as director on 31 Dec 2024
17 Mar 2026 Gazette

Gazette Dissolved Voluntary

2 Jul 2025 Confirmation Statement

Confirmation statement made on 21 Jun 2025 with no updates

24 Jun 2025 Officers

Termination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025

9 Jan 2025 Officers

Appointment of Samuel Jenkinson as director on 1 Jan 2025

9 Jan 2025 Officers

Termination of Anthony Higham as director on 31 Dec 2024

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 months ago on 17 Mar 2026

Confirmation statement made on 21 Jun 2025 with no updates

10 months ago on 2 Jul 2025

Termination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025

10 months ago on 24 Jun 2025

Appointment of Samuel Jenkinson as director on 1 Jan 2025

1 years ago on 9 Jan 2025

Termination of Anthony Higham as director on 31 Dec 2024

1 years ago on 9 Jan 2025